TAI:1795

Lotus Pharmaceutical Co., Ltd. · TAI · Healthcare · TWD · FY for 2025

Figures on this page computed 2026-11-08 13:10 UTC

Last close

n/aTWD

Market data

9.2xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
TWD
- computed
- Computed from the filing for 2025
6.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
23.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
15.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
2.35Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
3.5%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
TWD
- computed

Safety is the furthest below its sector's middle: 0.37 against 0.57 on the market's range.

All from 100

lens 2 of 9

Sales

347

2016-12-31 to 2025-12-31100 at the start347

Sales: 100.00 on 2016-12-31 to 347.47 on 2025-12-31, up 247%.

Shares in issue

110

2016-12-31 to 2025-12-31100 at the start110

Shares in issue: 100.00 on 2016-12-31 to 109.84 on 2025-12-31, up 10%.

Profit, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.

Sales is at 348, Shares in issue is at 110, against 100 in 2016.

Sales is at 348, Shares in issue is at 110, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100348
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Profit, where the first year is 100n/a
Not held.
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Shares in issue, where the first year is 100110
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD